BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04220866-completion@plaintrial.com
DTSTAMP:20261029T024429Z
DTSTART;VALUE=DATE:20220930
SUMMARY:Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination Wit
 h Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Al
 one as the First Line Treatment of Metastatic or Unresectable\, Recurrent 
 Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002) — estimated 
 completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04220866
URL:https://plaintrial.com/trial/NCT04220866
END:VEVENT
END:VCALENDAR